fashion -WSS

fashion

author：entertainment 2025-08-12 08:25:24 - browse：7629

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： STAT letters to the editor on burnt

hotspot

explore

WSS

What PEPFAR has meant on the ground in Ukraine

Intercept Pharmaceuticals sells itself for less than $1 billion

What causes an itch? Researchers may have solved the mystery

Roche to buy Carmot Therapeutics, developer of obesity drugs

After a drawn out lobbying fight, ARPA

Roche to buy Carmot Therapeutics, developer of obesity drugs

entertainment

fashion

knowledge

In Memoriam: Notable people who died in 2023

Inequities make cancer less preventable for women: report

Virginia high school admissions case could be legal follow

How one patient went off dialysis — and others can too

Bright Health sells Medicare Advantage business to Molina

WHO recommends dropping component of many flu vaccines

Activists slam private health insurers over coverage restrictions

Researchers use wearables data and AI to predict preterm birth risk

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare drug price negotiation program allowed for now

focus

Medicaid, Medicare dual

What PEPFAR has meant on the ground in Ukraine

Paxlovid should be available without a positive Covid test

Teach medical students about patients with intellectual disabilities

Why sickle cell disease is getting the first CRISPR treatment

Medicare drug price negotiation program allowed for now

entertainment

hotspot

explore

leisure time